131 related articles for article (PubMed ID: 1970487)
1. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms.
Tefferi A; Thibodeau SN; Solberg LA
Blood; 1990 May; 75(9):1770-3. PubMed ID: 1970487
[TBL] [Abstract][Full Text] [Related]
2. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.
Ganser A; Janssen JW; Ottmann OG; Seipelt G; Eder M; Becher R; Lindermann A; Herrmann F; Schulz G; Mertelsmann R
Leukemia; 1991 Jun; 5(6):487-92. PubMed ID: 1676079
[TBL] [Abstract][Full Text] [Related]
4. Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia.
Jowitt SN; Yin JA; Saunders MJ
Blood; 1993 Jul; 82(2):613-8. PubMed ID: 8101105
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic approach to the analysis of clonal proliferation in hematologic disorders.
Morita K; Tsukamoto N; Karasawa M; Omine M
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1414-22. PubMed ID: 2576494
[TBL] [Abstract][Full Text] [Related]
6. Detection of monoclonal hematopoiesis using restriction fragment length polymorphism (RFLP) of phosphoglycerokinase (PGK) gene in a patient with hypoplastic myelodysplastic syndrome (MDS).
Miyazaki Y; Kuriyama K; Fujiwara T; Jinnai I; Hirashima K; Tomonaga M
Intern Med; 1993 Mar; 32(3):255-6. PubMed ID: 8101108
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.
Janssen JW; Buschle M; Layton M; Drexler HG; Lyons J; van den Berghe H; Heimpel H; Kubanek B; Kleihauer E; Mufti GJ
Blood; 1989 Jan; 73(1):248-54. PubMed ID: 2562924
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin of pituitary adenomas.
Herman V; Fagin J; Gonsky R; Kovacs K; Melmed S
J Clin Endocrinol Metab; 1990 Dec; 71(6):1427-33. PubMed ID: 1977759
[TBL] [Abstract][Full Text] [Related]
9. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Karasawa M; Omine M; Naruse T
Br J Haematol; 1993 Apr; 83(4):589-94. PubMed ID: 8100140
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Murayama N; Inoue M; Ishihara S; Tawa A; Okada S; Kawa-Ha K
Blood; 1991 Mar; 77(6):1161-3. PubMed ID: 1672097
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein B; Fearon ER; Hamilton SR; Preisinger AC; Willard HF; Michelson AM; Riggs AD; Orkin SH
Cancer Res; 1987 Sep; 47(18):4806-13. PubMed ID: 2887283
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome in three patients with myelodysplastic syndrome showing polyclonal hematopoiesis.
Karasawa M; Tsukamoto N; Sakai H; Okamoto K; Maehara T; Naruse T; Morita K; Sato S
Acta Haematol; 1999 Mar; 101(1):46-9. PubMed ID: 10085438
[TBL] [Abstract][Full Text] [Related]
13. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M
Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034
[TBL] [Abstract][Full Text] [Related]
14. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses.
Abrahamson G; Boultwood J; Madden J; Kelly S; Oscier DG; Rack K; Buckle VJ; Wainscoat JS
Br J Haematol; 1991 Dec; 79(4):550-5. PubMed ID: 1685326
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis in patients with acquired aplastic anemia.
van Kamp H; Landegent JE; Jansen RP; Willemze R; Fibbe WE
Blood; 1991 Dec; 78(12):3209-14. PubMed ID: 1683796
[TBL] [Abstract][Full Text] [Related]
16. Clonal haematopoiesis in children with acquired aplastic anaemia.
Tsuge I; Kojima S; Matsuoka H; Abe T; Kamachi Y; Torii S; Matsuyama T
Br J Haematol; 1993 May; 84(1):137-43. PubMed ID: 8338766
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.
Bartram CR; Ludwig WD; Hiddemann W; Lyons J; Buschle M; Ritter J; Harbott J; Fröhlich A; Janssen JW
Leukemia; 1989 Apr; 3(4):247-56. PubMed ID: 2564452
[TBL] [Abstract][Full Text] [Related]
18. The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia.
Tsukamoto N; Karasawa M; Maehara T; Okamoto K; Sakai H; Naruse T; Morita K; Tsuchiya J; Omine M
Ann Hematol; 1996 Feb; 72(2):61-5. PubMed ID: 8597608
[TBL] [Abstract][Full Text] [Related]
19. Clonal composition of benign and malignant human thyroid tumors.
Namba H; Matsuo K; Fagin JA
J Clin Invest; 1990 Jul; 86(1):120-5. PubMed ID: 1973172
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
